Lymphomas
131 results
1 - 100
Antibody therapies for lymphoma in children- Interferon‐alpha for maintenance of follicular lymphoma
- Chemotherapy plus Rituximab versus chemotherapy alone for B‐cell non‐Hodgkin's lymphoma
- Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review
- Interventions for previously untreated patients with AIDS‐associated Non‐Hodgkin´s Lymphoma
- Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma: Cochrane systematic review
- Therapeutic interventions for Burkitt lymphoma in children: Cochrane systematic review
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
- The role of additional radiotherapy for primary central nervous system lymphoma
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- The role of high‐dose chemotherapy with autologous stem cell transplantation in adults with mature T‐cell lymphomas
- Interventions for treating AIDS‐associated Hodgkin´s lymphoma in treatment‐naive adults
- Anthracycline-containing regimens for treatment of follicular lymphoma in adults: Cochrane systematic review
- High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults
- Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early‐stage Hodgkin’s lymphoma
- Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma
- High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
- Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review
- High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
- Positron emission tomography‐adapted therapy for first‐line treatment in adults with Hodgkin lymphoma
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
- Interim PET‐results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta‐analysis of prognostic factor studies
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis
- Interventions for mycosis fungoides
- Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
- Biosimilar monoclonal antibodies for cancer treatment in adults
- Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer
- Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
- Vaccines for prophylaxis of viral infections in patients with hematological malignancies: Cochrane systematic review
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview
- Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia: Cochrane systematic review
- Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer: Cochrane systematic review
- Alkylating agents for Waldenstrom's macroglobulinaemia
- Interventions for early stage Hodgkin's disease in children: Cochrane systematic review
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
- Yoga in addition to standard care for patients with haematological malignancies
- Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
- Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
- Topical tacrolimus for atopic dermatitis